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Solanum xanthocarpum is an important part of natural remedies for lung in Ayurveda. Lung cancer metastasis is a 
major challenge in the present time. Expressions and activation of focal adhesion kinase (FAK) and extracellular receptor 
kinases 1 and 2 (ERK1/2) are key checkpoints in cancer which lead to an invasion, epithelial-mesenchymal transition (EMT) 
and metastatic progression. In this study, the efficacy of the whole plant and root crude extracts prepared in ethyl acetate and 
chloroform on highly metastatic lung cancer cell line A549 was evaluated. The effect of crude extracts on cell migration was 
scrutinized using transwell migration assessment. The phosphorylated forms of proteins, pFAK and pERK1/2 levels, were 
estimated using ELISA. Zymography technique was utilized to evaluate the activities of MMP-2 and MMP-9 proteins. The 
EMT markers, vimentin and N-cadherin gene expressions were analyzed using semi-quantitative RT-PCR. The extracts 
significantly reduced single-cell migration. The expression levels of pFAK and pERK1/2 notably decreased and FAK and 
ERK1/2 remained unchanged. Moreover, gelatinase activity, vimentin and N-cadherin expression were also significantly 
reduced in treated cells compared to untreated cells. The crude extracts of S. xanthocarpum impaired the metastatic 
progression of A549 cells in vitro. 
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Introduction 
Solanum xanthocarpum Schrad. & H. Wendl. (syn. 
S. virginianium L.), is a traditional and scientifically
acclaimed medicinal plant for its numerous
therapeutic effects and immunomodulatory actions on
lung-related ailments. S. xanthocarpum is known as
Kantakari in Sanskrit1-4. The plant is an integral part
of many alternative medicinal practices in Indian
villages and folk cultures. Numerous ancient
scriptures in ancient sciences such as Ayurveda,
Unani, and Siddha mention the plant for its
medicinally significant properties. The whole plant
and different parts of the plant are useful in Ayurvedic
formulations, such as Dasamoolarishta,
Chavanaprasha, Vyaghri tailam, Vyaghri ghrtam,
Vyaghriyadi kwatha, etc1. Interestingly, even the
fume of the seeds has beneficial effects5. Literature
is available for its anti-inflammatory and
immunomodulatory properties apart from anti-
asthmatic, anti fertility4, antihyperglycaemic and anti-
larvae4 activities. S. xanthocarpum has extremely
beneficial efficacy in respiratory tract related
ailments3,4. Tribal practitioners in the South Gujarat 
region of India use the plant in the therapy of cancer. 
The plant is reported to have a wide variety of 
secondary metabolites such as alkaloids, phenolics, 
flavonoids, sterols, saponins and their glycosides, 
carbohydrates, fatty acids, tannins, and amino acids2,6. 
The secondary metabolites namely stigmasterol, 
carpesterol, diosgenin and lupeol are reported to be 
present in the plant and show immunomodulatory and 
anti-inflammatory effects3,7. In a previous study, 
authors reported in silico interaction of Lupeol, one of 
the active phytochemicals present in the plant, to ERK 
pathway proteins8. 
 
Metastasis is the most devastating hallmark of 
cancer with more than 90% of deaths worldwide9-13. 
Antimetastatic agents’ development and resource 
findings are the most decisive in cancer research14. In 
the present time, back to nature approach is highly 
accepted. A large amount of plant-based molecules 
are developed and approved for the anticancer and 
antimetastatic therapies15,16. Many medicinal plants, 
Ayurvedic, Siddha, Unani, and other traditional 
formulations have proved their potential for cancer 
inhibition, suppression of metastasis, and easing many 








Lung cancer metastasis is very difficult to 
handle18. A majority of lung cancer patients (80-85%) 
are diagnosed with non small cell lung carcinoma 
(NSCLC), which is highly metastatic and thus, has 
limited therapeutic options19. The Ras-Raf-MEK-
ERK cascade is a major pathway and highly activated 
in NSCLC. Once activated, extracellular receptor 
kinases (ERK1 and ERK2) can facilitate epithelial to 
mesenchymal transition (EMT) by increasing the 
expression of EMT transcription factors, cell motility 
and invasion via increased repression of E-cadherin 
and activation of N-cadherin and matrix matallo 
proteinases MMPs20. Mitogen-activated protein 
kinase kinase (MAP2K or MEK) MEK1 and 2 carry 
out the phosphorylation of their sole target ERK1/2. 
However, the other factors, such as activated focal 
adhesion kinase (pFAK) can also activate ERK1/221 
FAK plays a major role in cancer cell proliferation, 
survival, and metastasis by dynamically responding to 
changes in ECM, growth factors, and nutrient 
availability22. 
On the other hand, many reports of the therapeutic 
potential of S. xanthocarpum on respiratory and 
bronchial disorders exist, which provides a 
preliminary rationale for analyzing the plant’s effects 
on a lung cancer cell. Thus, A549, a highly metastatic 
NSCLC cell line was selected for the analysis of the 
plant’s effects. 5-Fu, a classical anticancer drug, was 
used as a standard. In a previous study, the authors 
reported the superoxide anion and nitrite reduction 
potential of the plant along with the collective 
migration ability of the A549 cells2,23. In the present 
study, the effects of the crude extracts of the whole 
plant and root were analyzed on the single-cell 
migration and the expression levels of the checkpoint 
proteins of the metastasis, FAK, pFAK, ERK, and 
pERK. The gelatinase activity is a measure of 
invasiveness in the cancer cells. The efficacy of the 
plant on the MMP-2 and MMP-9 proteins was 
accessed. Expression levels of EMT marker genes – 
vimentin and N-cadherin levels were scrutinized. 
 
Materials and Methods 
 
Plant collection and identification 
Whole plants of S. xanthocarpum were collected 
from the Girls’ hostel campus of Veer Narmad South 
Gujarat University, Surat, India during the March-
April period of 2015. The identity of the collected 
plant was authenticated by Prof. M. H. Parabia, 
Advisor, Bapalal Vaidya Botanical Research Centre 
(BVBRC), VNSGU, Surat. A voucher specimen 
(BVBRC1204) was deposited at BVBRC, Department 
of Biosciences, Veer Narmad South Gujarat 
University, Surat, Gujarat, India. 
 
Plant extracts preparation and Cell culture 
The crude extracts of S. xanthocarpum whole 
plants and roots were prepared as described 
previously2. Five different dilutions of all the extracts 
(50, 100, 200, 300, 500 µg/mL) were used for the 
assays. Extracts of the whole plant and roots with 
ethyl acetate were abbreviated as SEW, SER 
respectively and chloroform extracts of the whole 
plant and roots were abbreviated as SCW, SCR 
respectively2. The human lung carcinoma A549 cells 
were obtained from NCCS, Pune and maintained in 
humidified conditions (5% CO2 and 37 °C). The cells 
were propagated up to 70-80% confluence for each 
assay. 
 
Transwell cell migration assay 
Effect of the plant crude extracts on the migration 
ability of A549 cells was observed using transwell 
chamber migration assay. Exactly 200 µL of the 
serum-less medium along with 1×104 cells, consisting 
of an appropriate extract were seeded in the 
polycarbonate transwell membrane assay plate, upper 
chamber consisting pore size 8 µm (TCP152, 
Himedia, growth area of the well = 0.33 cm2). Lower 
wells were filled with 750 µL of 10% FBS containing 
a medium. The plate was incubated for 12 hours at  
37 °C in 5% CO2. More than five different fields were 
analyzed and migrated cells were counted (Corning 
life science, 2008). Results were expressed as 
percentage migration considering the field of view of 
the microscope. The equations given below were used 
for calculating % migration. 
 
Number of migrated cells
Avg migrated cells
Field of view
area of well 
 
% Migration
Number of migrated cells
Number of inserted cells
100 
 
Cell lysis and total protein extraction 
Cell lysates for protein expression analysis were 
prepared for cells treated with S. xanthocarpum plant 
extracts, SCR, SCW, SER, SEW (300 and 500 
µg/mL), and untreated cells (control). Cells were 
scraped off their respective plates re-suspended, 
centrifuged, and washed twice using chilled PBS. Cell 
extraction buffer (Invitrogen, FN0011) supplemented 
with PMSF and protease inhibitor cocktail was added 
into cell palate after discarding the supernatant. The 
complete process of vortexing the samples for  




30 minutes with 10 minutes intervals was performed 
on ice. Then samples were centrifuged at 13000 rpm at  
4 °C for 10 minutes. Lysates were then stored at -40 °C 
for further use. 
 
Expression analysis of total FAK, ERK1/2, pFAK and 
pERK1/2 using ELISA 
The samples were checked for protein contents 
using the Lowry method24. Cell lysates were diluted 
as per total protein contents. The effects of treatments 
on quantitative levels of crucial proteins were 
analyzed using a respective ELISA kit as per the 
instructions given in the kit. Anti-pan FAK and anti-
phsopho- FAK (Y397) antibody-based ELISA kit 
(PEL-FAK-Y397, RayBiotech) was used For FAK 
and pFAK estimation. For pan ERK1/2 and pERK1/2, 
the ELISA kit (PEL-Erk-202-T, Ray Biotech) 
comprising anti-pan-ERK1/2 for total Erk1/2, human, 
mouse and rabbit anti-phospho-Erk1 (Thr202/Tyr204) 
and human, mouse and rabbit anti-phospho-Erk2 
(Thr185/Tyr187) was used. Absorbance was 
measured at 450 nm. 
 
Gelatine zymography 
Gelatinase activities of cells were observed using 
zymography. MMP-2 (ENZ-769) and MMP-9  
(ENZ-438) standards were obtained from GenxBio. 
The complete procedure was followed as available in 
the protocol with some modifications25. SDS PAGE 
gel (8% Resolving) was co-polymerised with 0.1% 
gelatine. The 6.5% stacking gel comprising an 
appropriate lane was made. After adding an equal 
amount of protein samples in the appropriate lanes, 
the gel was subjected to electrophoresis. After that, 
the gel was washed and incubated for 36 hours. Next, 
0.25% Coomassie brilliant blue was used to stain the 
gel. The gel was de-stained with acetic acid and 
ethanol mixture. Bands were observed and analyzed 
using Image J 1.46r (NIH, USA). 
 
Determination of expression levels of EMT markers-Vimentin 
and N-cadherin 
Cellular RNA was isolated using the RNA 
extraction kit (MB602, Himedia, India) and cDNA 
synthesis from the extracted RNA was carried out 
using cDNA synthesis kit (MBT076, Himedia, India) 
according to the manufacturer’s instructions. Relative 




was determined by the semiquantitative RT-PCR 
method and the absorbance relative to control was 




Transwell cell migration  
Cell migration towards chemo-attractant is one of 
the most important properties of metastasizing cells 
and transwell migration assay is an accurate method 
for scrutinizing single-cell migration capacity. In the 
present study, Fig. 1a shows the number of cells 
migrated from the upper chamber to the lower 
chamber, towards the chemo-attractant during  
15 hours under the influence of the testing samples, 
plant extracts. The total percentage of migration was 
found for each of the wells with the counted cells. The 
results are presented in Fig. 1b for the plant extract-
treated cells. It indicates the effect of the plant 
extracts on the migration of the cells. Control well 
exhibited the heavily migrated cells. The well treated 
with 5-Fu did not show a migrated cell. The plant 
extract treatment at 300 and 500 µg/mL affected cells 
migration percentage and exhibited a huge impact on 
 
 
Fig. 1 — A549 cells migration, a) Control and treated with the plant extracts and b) A549 cells migration (in %)–Control and the plant 
extract (300 and 500 µg/mL ) treated cells. Statistical significance is shown as *p <0.05, ***p <0.005, #p <0.001.  




cell migration. SEW 300 µg/mL treated cells showed 
the most impaired transwell migration. The migration 
was significantly reduced in the cells treated with 
crude extracts at 500 µg/mL concentration. 
 
Estimation of the proteins (FAK, pFAK, ERK, pERK) 
ELISA estimates expression levels of the crucial 
proteins in the cell lysates. The present study aimed to 
examine the levels of key proteins in the A549 cells 
metastasis. Fig. 2 explains the effects on the amount 
of proteins [FAK and pFAK] quantified in the 
differently treated cells with the plant extracts, SCR, 
SCW, SER, SEW (300 and 500 µg/mL). The results 
suggest that the plant extracts show a noticeable 
decrease in FAK and pFAK expression. It is 
important to note that total FAK is decreased in SCW, 
SER, and SEW treated cells, whereas SCR treated 
cells showed increased FAK. Besides, no dose-
dependence in the decrease of total FAK was 
observed, except in the SEW treated cells. In the case 
of pFAK concentration, except SCR treatment, SCW, 
SER, and SEW showed a dose-dependent effect on 
the A549 cells. SEW decreased pFAK secretion more 
significantly. 
ERK1/2 is the key protein complex in metastatic 
progression. The activation, phosphorylation of the 
proteins is the crucial checkpoint in many biological 
events. Fig. 3 shows the effects of the plant extracts 
on ERK1/2 and pERK1/2 levels in the A549 cells. It 
is clearly observable, that pan ERK1/2 level is not 
affected significantly, but pERK1/2 levels are 
decreased drastically under the treatment of all the 
plant extracts. The plant shows effects in a dose-
dependent manner on pERK1/2 expression. The 
lowest expression was observed in SEW 500 µg/mL 
treated cells. 
 
Zymography (MMP-2 and MMP-9 estimation) 
Determination of MMP-2 and MMP-9 - gelatinase 
enzymes provide an important understanding of the 
invasiveness of the cells. In the present study, 
Zymography technique based results are obtained. 
Fig. 4 shows the zymogram in the treated A549 cells. 
Fig. 4a shows the MMP-2 and MMP-9 expression in 
control and the plant extract treated cell lysates. Co 
 
Fig. 2 — Total FAK and pFAK expression in A549 cells treated
with the plant extracts, a) Total FAK expression in the cells
treated with the crude extracts and b) pFAK expression in the
treated cells. Statistical significance is shown as *p <0.05,
**p <0.01,*** p <0.005, #p <0.001. 
 
Fig. 3 — Total ERK1/2 and pERK1/2 expression in A549 cells 
treated with the plant extracts, a) Total ERK1/2 expressions in the
cells treated with the crude extracts and b) pERK1/2 expression in
the treated cells. Statistical significance is shown as *** p <0.005, 
#p <0.001. 




=Control, 1= SCR, 2=SCW, 3= SER, 4= SEW treated 
cell lysates. The decolourized area of the gel indicates 
the gelatinase activity. The decolourized bands were 
measured with the help of ImageJ 1.46r (NIH, USA) 
and intensities were calculated relative to control.  
Fig. 4b & c shows the MMP-2 and the MMP-9 
activity in the cells treated with 300 µg/mL of SCR, 
SCW, SER and, SEW respectively.  
 
Semi-quantitative RT-PCR for detection of vimentin and N-
cadherin expressions 
EMT is a major hallmark through which cancer 
cell disseminates from the primary site and migrate. 
Expression levels of mesenchymal markers- Vimentin 
and N-cadherin were examined for the cells treated 
with the extracts. Fig. 5a explains the gene expression 
of vimentin and N-cadherin in (C) Control cells, (1) 
SCR 300 µg/mL, (2) SCW 300 µg/mL, (3) SER 300 
µg/mL, (4) SEW 300 µg/mL, (5) SCR 500 µg/mL, (6) 
SCW 500 µg/mL, (7) SER 500 µg/mL, and (8) SEW 
500 µg/mL treated cells. The expression was semi-
quantified using Image J 1.46r, the expression of the 
gene relative to control was presented in Fig. 5b & c. 
Vimentin expression was significantly low in all the 
treated cells. N-cadherin also reduced in a significant 
amount. More decrease was observed in the cells 
treated with a higher concentration of the plant 
extracts. SEW again showed the maximum decrease 
in the expression of both genes. 
 
Discussion 
The major characteristic of metastasis is cell 
migration. Evaluation of A549 cell migration under 
the influence of the plant in the previous experiment 
showed the efficacy of the crude extracts. Especially 
SEW treatment reduced the wound healing- collective 
cell migration effectively22. While wound healing 
assay is the most convenient and accurate method to 
analyze cell mass or group migration, transwell cell 
migration provides a step further to study single-cell 
motility (mesenchymal and amoeboid migration)26. 
Fig. 1a is a representation of cells migrated transwell 
in the direction of chemo-attractant. The cells in 
untreated conditions clearly show the ability of A549 
cells to migrate. In contrast, a huge decrease in cell 
migration in the SCR, SCW, SER, and SEW  
(300 µg/mL) treated wells illustrate the clear 
conditions. Despite maintaining the viability, cells did 
 
 
Fig. 4 — Zymography: A549 cells treated with plant extracts a) Zymogram- gelatinase activity is shown as colorless bands, b) MMP-2 
activity quantified using ImageJ in the treated cells, and c) MMP-9 activity quantified by ImageJ in the treated cells. Statistical
significance is shown as *p <0.05, **p <0.01, ***p <0.005, #p <0.001. 
 




not manage to migrate through the membrane, which 
is a critical and noteworthy observation. Fig. 1b 
shows the % migration of the cells treated with two 
different dilutions of the crude extracts. SCW and 
SEW treatment showed the impact and the higher 
dilution treatments exhibited a drastic decrease in the 
ability of the cells to migrate transwell. A huge cell 
migration reduction in the whole plant treatment is a 
salient finding of the study. Interestingly, no 
cytotoxicity was observed at this concentration of 
plant2. Many reports are available suggesting the anti-
fertility properties of the plant3,4. It is reported that the 
plant seed shows the depletion of sperm motility in 
animals27. Although sperm motility depends on major 
sperm protein (MSP) and has no biochemical or 
structural relationship to actin-myosin functions, a 
study on C. elegans showed that the ‘molecular 
clutch’ principles apply to the MSP cytoskeleton 
system also along with actomyosin-based cell 
motility28. Hence, the clutch concept remains robust 
in cell motility for different cytoskeletons. However, 
the possible correlations between cancer cells and 
sperm motility remain open for speculations. 
 
FAK and ERK signalling events play active roles 
in actin-myosin cytoskeleton modulation and 
motility29-31. FAK and autophosphorylated FAK at 
tyrosine 397 serve as the prognostic markers of 
metastatic cancer cells32-34. FAK and pFAK (y397) 
estimation in the cells treated with the plant extracts 
was carried out. The plant extracts SCW, SER, and 
SEW showed a significant decrease in total FAK as 
well as pFAK expression as shown in Fig. 2a & b. 
SEW treatment decreased the FAK expression the 
most. These results correlate with the anti-migratory 
effects of the plants. 
 
The observations were stupendous in the case of 
ERK and pERK expressions. Fig. 3a presents the total 
ERK1/2 expression in the cells when treated with the 
plant extracts. It is clear from the results that ERK1/2 
expression remains unaffected in each treated group. 
Nevertheless, the results shown in Fig. 3b are 
intriguing. The expression of phosphorylated ERK1/2 
decreased in all the cells treated with the plant 
extracts. ERK1/2 phosphorylation is the process, 
which is carried out by many possible activators. 
ERK1/2 is a downstream component of the Ras-Raf-
MEK-ERK cascade and its activation leads to many 
other sequential events35. Upon activation by Ras, Raf 
triggers MAP2K (MEK1/2). MEK1/2 are the only 
identified ERK1/2 activators that can phosphorylate 
ERK1/2 on both tyrosine and threonine residues, thus 
named dual-specificity protein kinases. Their only 
substrate is ERK1/2 36. Hence, the decreased pERK1/2 
instantly correlates with the less activity of MEK. 
ERK activation is also affected by other activators 
such as FAK action, reactive oxygen species, nitrites 
etc37-39. In the present results of FAK and pFAK 
expression, a reduction was observed when the cells 
were treated with the plant extracts. Thus, reduced 
activity of FAK also might have contributed to 
depletion in ERK1/2 phosphorylation. More than a 
two-fold decrease in the expression of pERK was 
noticed in the cells treated with 500 µg/mL dilution of 
all the crude extracts. SEW (500 µg/mL) treated cells 
reduced pERK1/2 levels up to three folds. These 
 
Fig. 5 — Gene expression analysis: vimentin and N-cadherin, a)
Gene expression in differently treated cells, b and c) Semi-
quantitative representation of the genes expressed. Statistical
significance is shown as *p <0.05, **p <0.01, ***p <0.005,
#p <0.001  
 




results showed a salient connection with the other 
observations in the study, viz. superoxide anion and 
nitrite reduction, collective cell migration reported 
earlier and FAK-pFAK expressions2. 
 
Successful inhibition of FAK and ERK1/2 
activation can directly reflect upon the anti-invasive 
properties of the cells as the pFAK and pERK1/2 are 
positively correlated with MMP-2 and MMP-9 
activity40-42. MMP-2 and MMP-9 gelatinase activity is 
closely related to apoptosis, ECM remodelling, 
migration, and invasion43. Thus, following the FAK 
and ERK1/2 estimation, Zymography was utilized for 
checking the activity of gelatinase enzymes MMP-2 
and MMP-9. Fig. 4a shows the gelatinase activity 
bands wherein, standards of MMP-2 & 9 are shown in 
the first two tracks. MMP-2 bands are clearly 
observed in the plant extract-treated cells, while 
MMP-9 bands are inconspicuous. A drastic decrease 
in MMP-2 activity was observed in the bands in 
comparison to control. Fig. 4b & c show the 
gelatinase activity measured in comparison to control. 
The bands in ethyl acetate extract-treated cells 
showed fewer gelatinase activities. 
 
All of these proteins pFAK, pERK, MMP-2, and 
MMP-9 are associated with various signalling 
pathways such as TGF-β signalling, receptor tyrosine 
kinase, wnt-notch signalling etc., which all lead to 
epithelial-mesenchymal transition (EMT)44. The 
transition of epithelial to mesenchymal cell types is a 
reversible process and is called the mesenchymal-
epithelial transition (MET). EMT is the central 
regulator of metastatic progression45. Typically, 
epithelial cells are immobile, organized in a layer, 
with well-defined junctions, in the fashion of apical-
basal polarity. The transition of these cells into 
mesenchymal cell types enables them to exhibit 
motility and invasiveness by adopting an elongated 
shape with front-back polarity46,47. EMT is the 
fundamental process found in embryogenesis, where 
it is required for organogenesis. In adults, the process 
is exploited in a controlled manner for wound healing 
or in the case of cancer47. High expression levels of 
N-cadherin and vimentin are signatures of a 
mesenchymal phenotype and increased during EMT 
in various cancer cells including NSCLC47-50. In the 
present study, confirmation of the levels of vimentin 
and N-cadherin provided an insight into the  
S. xanthocarpum extracts’ effects on A549 cells. 
Semi-quantitative RT-PCR was used to evaluate the 
levels of the mRNA expressed for vimentin and  
N-cadherin after an equal number of cycles in 
untreated versus treated cells. β- actin gene was used 
as a reference housekeeping gene. Fig. 5 shows the 
expression of the cells treated with the plant extracts 
and control cells. It is evident from the result that, 
both the mesenchymal markers gene expression 
reduced supremely. For semi-quantitative estimation, 
ImageJ 1.46r plot values were utilized for the 
calculation of expression relative to β- actin. The 
expression data suggest the decrease in vimentin and 
N-cadherin expression levels in comparison to control 
following the treatment of plant extracts Fig. 5b & c. 
 
Vimentin is an intermediate filament found in 
mesenchymal cells. It is important to note here that 
the vimentin expression is necessary for the cancer 
cells to maintain the ERK1/2 phosphorylated and the 
pERK1/2 is essential to maintain the fidelity of 
signalling pathways leading to proliferation and 
metastasis events. Additionally, vimentin does not 
bind with ERK1/2 but only binds to the 
phosphorylation lip of pERK1/2, covers and protects 
it from dephosphorylation49. In the present study, 
increased ERK1/2 and decrease in the pERK 
expression correlates with the decrease in the 
expression of vimentin. Hence, this suggests a definite 
loss of vimentin–pERK reciprocal complex. In the 
same way, N-cadherin is also associated with 
sustained MAPK-ERK activation by FGF-2. Cadherin 
switch, i.e., E-cadherin to N-cadherin is a crucial 
hallmark; and increased N-cadherin is associated with 
escape from anoikis, cell migration, and invasion47. 
Thus, a decrease in two major mesenchymal markers 
expression levels are indicators of the plant’s action 
on the metastatic potential of the A549 cells. The 
plant extracts modulate several events through 
inhibition of pFAK, pERK, MMP-2, MMP-9, 
vimentin and N-cadherin expressions and thus 
affecting the migratory ability of the cells. Especially, 
the whole plant crude extracts showed outstanding 
efficacy in all the analyses. Thus, the traditionally 
important and noted plant, S. xanthocarpum, has 
significant efficacy on the metastatic cell line of lung 
cancer. Further investigations on the other molecular 
and metabolical pathways within the cells treated with 
the plant can provide promising outcomes in the 
direction of antimetastatic treatments. 
 
Conclusion 
Solanum xanthocarpum, a member of 
Dashamularisth and numerous other Ayurvedic 
formulations is well known for its uses in different 




aliment. However, its potential use on lung cancer is 
not reported. In the present study, anti-metastatic 
properties of the roots and whole plant crude extract 
were evaluated against lung cancer (A549 cells). The 
whole plant crude extracts treatments significantly 
hamper cell migration, reduce pERK1/2 and pFAK, 
decrease expression levels of EMT markers vimentin, 
N-cadherin, deplete the activities of MMP-2 and 9. 
Hence, the plant shows promising therapeutic potential 
for metastatic progression in human lung cancer. 
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